GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » 3-Year Revenue Growth Rate

Sinclair Pharma (XPAR:SPH) 3-Year Revenue Growth Rate : -11.50% (As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is Sinclair Pharma 3-Year Revenue Growth Rate?

Sinclair Pharma's Revenue per Share for the six months ended in Jun. 2018 was €0.06.

During the past 12 months, Sinclair Pharma's average Revenue per Share Growth Rate was 22.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -11.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was -12.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was -12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Sinclair Pharma was 61.80% per year. The lowest was -26.30% per year. And the median was 0.00% per year.


Competitive Comparison of Sinclair Pharma's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Sinclair Pharma's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinclair Pharma's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sinclair Pharma's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Sinclair Pharma's 3-Year Revenue Growth Rate falls into.



Sinclair Pharma 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Sinclair Pharma  (XPAR:SPH) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Sinclair Pharma 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinclair Pharma (XPAR:SPH) Business Description

Traded in Other Exchanges
N/A
Address
Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.